Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...
Main Authors: | Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
National Institute for Health Research
2016
|
פריטים דומים
-
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
מאת: Thomas RE Barnes, et al.
יצא לאור: (2016-04-01) -
Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
מאת: Barnes, T, et al.
יצא לאור: (2017) -
Disclosing the potential impact of placebo controls in antidepressant trials
מאת: Stephanie C. Chen, et al.
יצא לאור: (2015-06-01) -
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
מאת: Thomas RE Barnes, et al.
יצא לאור: (2017-09-01) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
מאת: Crawford, A, et al.
יצא לאור: (2014)